Harry
“Harry was well looked after, carefully monitored, and we felt supported by the staff every step of the way.”
Stephanie George and Lee Murdoch whose newborn son Harry took part in a study.
We are here to help you find out about health and social care research that is taking place across the UK.
“Harry was well looked after, carefully monitored, and we felt supported by the staff every step of the way.”
Stephanie George and Lee Murdoch whose newborn son Harry took part in a study.
“Unless we try things out we’d never get to know what would work”.
Stephen Burgess, rare cancer trial participant.
“Clinical research is vital to help make improvements for patients and the NHS”.
Irene Soulsby, cancer research participant.
We’ve rebuilt the UK Clinical Trials Gateway to make it easier to use. We will continue to improve our new ‘Be Part of Research’ site but we need your help. Feedback now.
Watch our animation to find out how participating in research can change lives and the future of healthcare. Read more about the motivations behind people taking part in research.
The number of people benefitting from clinical research has reached record highs this year. In 2018/19 research was delivered at every NHS trust across the country and we’re making it even easier for people to take part. Read the full story.
Who better for researchers to work with from the very start, than people living with the condition? You’re missing out on a wealth of knowledge and expertise by not including and working alongside patients. Just because I have dementia doesn’t mean I’m not capable of advising researchers on project design. In this blog, Wendy Mitchell (author of Sunday Times Bestseller 'Somebody I Used to Know') talks about her involvement in research.
"Women can be assured that menstrual cups are as leakproof as tampons and pads," reports BBC News.
'Doctors should prescribe statins to patients at a younger age to slash their odds of heart disease in later life, a study suggests' reports The Sun
Levetiracetam is as effective as phenytoin at stopping prolonged epileptic seizures in children. In this trial, levetiracetam stopped 70% of children convulsing compared with 64% for phenytoin within 35 to 45 minutes. Adverse events were similar. This combined with the fact levetiracetam may be easier to administer safely make it an important option. Most epileptic seizures stop by themselves within a few minutes, but sometimes they continue for much longer. If this happens emergency treatment with IV benzodiazepines is recommended. If these fail, IV phenytoin is currently the commonest drug recommended, but is a particularly complicated drug to use and has potential interactions with other drugs. This NIHR funded study shows that levetiracetam may be preferable to phenytoin, with comparable safety and efficacy profiles but potentially simpler administration.